{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:00:00Z","timestamp":1775743200775,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Huaian Science and Technology Plan Project","award":["HAB2024013"],"award-info":[{"award-number":["HAB2024013"]}]},{"name":"Science and Technology Development Foundation of Xuzhou Medical University Affiliated Hospital","award":["XYFY202312"],"award-info":[{"award-number":["XYFY202312"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04249-8","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:14:38Z","timestamp":1772522078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulation of ferroptosis-related genes and the ACSL4-mediated ferroptosis-PD-L1 axis in prostate cancer pathogenesis"],"prefix":"10.1186","volume":"26","author":[{"given":"Chao","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengbing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"4249_CR1","doi-asserted-by":"publisher","first-page":"811044","DOI":"10.3389\/fpubh.2022.811044","volume":"10","author":"L Wang","year":"2022","unstructured":"Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019. Front public health. 2022;10:811044.","journal-title":"Front public health"},{"issue":"10437","key":"4249_CR2","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James ND, Tannock I, N\u2019Dow J, Feng F, Gillessen S, Ali SA, Trujillo B, Al-Lazikani B, Attard G, Bray F, et al. The <\u2009em>Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683\u2013722.","journal-title":"Lancet"},{"key":"4249_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jconrel.2021.04.035","volume":"334","author":"M Long","year":"2021","unstructured":"Long M, Liu X, Huang X, Lu M, Wu X, Weng L, Chen Q, Wang X, Zhu L, Chen Z. Alendronate-functionalized hypoxia-responsive polymeric micelles for targeted therapy of bone metastatic prostate cancer. J Controlled Release. 2021;334:303\u201317.","journal-title":"J Controlled Release"},{"issue":"2","key":"4249_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of Prostate Cancer. World J Oncol. 2019;10(2):63\u201389.","journal-title":"World J Oncol"},{"key":"4249_CR5","doi-asserted-by":"publisher","first-page":"104653","DOI":"10.1016\/j.critrevonc.2025.104653","volume":"208","author":"M Shirzad","year":"2025","unstructured":"Shirzad M, Salahvarzi A, Razzaq S, Javid-Naderi MJ, Rahdar A, Fathi-karkan S, Ghadami A, Kharaba Z, Romanholo Ferreira LF. Revolutionizing prostate cancer therapy: Artificial intelligence \u2013 Based nanocarriers for precision diagnosis and treatment. Crit Rev Oncol\/Hematol. 2025;208:104653.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"4249_CR6","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin D, Pi\u00f1eros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149:778\u201389. . https:\/\/doi.org\/10.1002\/ijc.33588","journal-title":"Int J Cancer"},{"issue":"6","key":"4249_CR7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/biom12060784","volume":"12","author":"P De la Rodr\u00edguezF, Caruana","year":"2022","unstructured":"Rodr\u00edguez F, Caruana P, De la Fuente N, Espa\u00f1ol P, G\u00e1mez M, Balart J, Llurba E, Rovira R, Ruiz R, Mart\u00edn-Lorente C, et al. Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges. Biomolecules. 2022;12(6):784. https:\/\/doi.org\/10.3390\/biom12060784","journal-title":"Biomolecules"},{"key":"4249_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/IJN.S230237","volume":"15","author":"C Xu","year":"2020","unstructured":"Xu C, Song R, Lu P, Chen J, Zhou Y, Shen G, Jiang M, Zhang W. A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy. Int J Nanomed. 2020;15:65\u201380.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4249_CR9","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1080\/10717544.2022.2110998","volume":"29","author":"Y Chen","year":"2022","unstructured":"Chen Y, Xu Z, Lu T, Luo J, Xue H. Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer. Drug Deliv. 2022;29(1):2705\u201312.","journal-title":"Drug Deliv"},{"issue":"1","key":"4249_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12944-024-02426-0","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Yang Z, Liu Y, Pei J, Li R, Yang Y. Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment. Lipids Health Dis. 2025;24(1):12.","journal-title":"Lipids Health Dis"},{"key":"4249_CR11","doi-asserted-by":"publisher","first-page":"1372215","DOI":"10.3389\/fimmu.2024.1372215","volume":"15","author":"Z Huang","year":"2024","unstructured":"Huang Z, Chen X, Wang Y, Yuan J, Li J, Hang W, Meng H. SLC7A11 inhibits ferroptosis and downregulates PD-L1 levels in lung adenocarcinoma. Front Immunol. 2024;15:1372215. https:\/\/doi.org\/10.3389\/fimmu.2024.1372215","journal-title":"Front Immunol"},{"issue":"7","key":"4249_CR12","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.4314\/tjpr.v22i7.4","volume":"22","author":"Y KongE, Xu","year":"2023","unstructured":"Kong E, Xu Y, Yang H. Total flavonoids of Rhizoma drynariae influence ferroptosis in osteobl asts via miR-205-5p\/GPX4 axis. Trop J Pharm Res. 2023;22(7):1379\u201386. https:\/\/doi.org\/10.4314\/tjpr.v22i7.4","journal-title":"Trop J Pharm Res"},{"key":"4249_CR13","doi-asserted-by":"publisher","first-page":"1098136","DOI":"10.3389\/fphar.2022.1098136","volume":"13","author":"X HongL, Wang","year":"2023","unstructured":"Hong L, Wang X, Cui W, Wang F, Shi W, Yu S, Luo Y, Zhong L, Zhao X. Construction of a ferroptosis scoring system and identification of LINC01572 as a novel ferroptosis suppressor in lung adenocarcinoma. Front Pharmacol. 2023;13:1098136. https:\/\/doi.org\/10.3389\/fphar.2022.1098136","journal-title":"Front Pharmacol"},{"issue":"8","key":"4249_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41419-024-06939-5","volume":"15","author":"X An","year":"2024","unstructured":"An X, Yu W, Liu J, Tang D, Yang L, Chen X. Oxidative cell death in cancer: mechanisms and therapeutic opportunities. Cell Death Dis. 2024;15(8):556.","journal-title":"Cell Death Dis"},{"issue":"2","key":"4249_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, Jiang X. Role of Mitochondria in Ferroptosis. Mol Cell. 2019;73(2):354\u2013e363353.","journal-title":"Mol Cell"},{"issue":"1","key":"4249_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41391-022-00583-w","volume":"26","author":"Y Wang","year":"2023","unstructured":"Wang Y, Ma Y, Jiang K. The role of ferroptosis in prostate cancer: a novel therapeutic strategy. Prostate Cancer Prostatic Dis. 2023;26(1):25\u20139.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"4249_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41420-023-01430-0","volume":"9","author":"J Liang","year":"2023","unstructured":"Liang J, Liao Y, Wang P, Yang K, Wang Y, Wang K, Zhong B, Zhou D, Cao Q, Li J, et al. Ferroptosis landscape in prostate cancer from molecular and metabolic perspective. Cell death discovery. 2023;9(1):128.","journal-title":"Cell death discovery"},{"issue":"10","key":"4249_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41585-024-00869-9","volume":"21","author":"PHA Cao","year":"2024","unstructured":"Cao PHA, Dominic A, Lujan FE, Senthilkumar S, Bhattacharya PK, Frigo DE, Subramani E. Unlocking ferroptosis in prostate cancer \u2014 the road to novel therapies and imaging markers. Nat Reviews Urol. 2024;21(10):615\u201337.","journal-title":"Nat Reviews Urol"},{"issue":"1","key":"4249_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41420-025-02528-3","volume":"11","author":"G Yu","year":"2025","unstructured":"Yu G, Chen K, Xu B, Cao Q. Mitochondrial SLC25A10 promotes prostate cancer progression by inhibiting ferritinophagy. Cell death discovery. 2025;11(1):242.","journal-title":"Cell death discovery"},{"key":"4249_CR20","doi-asserted-by":"publisher","first-page":"103392","DOI":"10.1016\/j.redox.2024.103392","volume":"77","author":"W Lai","year":"2024","unstructured":"Lai W, Zhu W, Wu J, Huang J, Li X, Luo Y, Wang Y, Zeng H, Li M, Qiu X, et al. HJURP inhibits sensitivity to ferroptosis inducers in prostate cancer cells by enhancing the peroxidase activity of PRDX1. Redox Biol. 2024;77:103392.","journal-title":"Redox Biol"},{"issue":"1","key":"4249_CR21","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/s41467-025-56494-6","volume":"16","author":"J Yang","year":"2025","unstructured":"Yang J, Lu X, Hao J-L, Li L, Ruan Y-T, An X-N, Huang Q-L, Dong X-M, Gao P. VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis. Nat Commun. 2025;16(1):1160.","journal-title":"Nat Commun"},{"issue":"3","key":"4249_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-021-00431-4","volume":"22","author":"AVR Kornepati","year":"2022","unstructured":"Kornepati AVR, Vadlamudi RK, Curiel TJ. Programmed death ligand 1 signals in cancer cells. Nat Rev Cancer. 2022;22(3):174\u201389.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4249_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","volume":"18","author":"X Jiang","year":"2019","unstructured":"Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B, Wu X, Ma J, Zhou M, Li X, et al. Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape. Mol Cancer. 2019;18(1):10.","journal-title":"Mol Cancer"},{"key":"4249_CR24","doi-asserted-by":"publisher","first-page":"112788","DOI":"10.1016\/j.intimp.2024.112788","volume":"140","author":"G Wu","year":"2024","unstructured":"Wu G, Pan B, Shi H, Yi Y, Zheng X, Ma H, Zhao M, Zhang Z, Cheng L, Huang Y, et al. Neutrophils\u2019 dual role in cancer: from tumor progression to immunotherapeutic potential. Int Immunopharmacol. 2024;140:112788.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"4249_CR25","doi-asserted-by":"publisher","first-page":"114868","DOI":"10.1016\/j.celrep.2024.114868","volume":"43","author":"K Xiao","year":"2024","unstructured":"Xiao K, Zhang S, Peng Q, Du Y, Yao X, Ng II, Tang H. PD-L1 protects tumor-associated dendritic cells from ferroptosis during immunogenic chemotherapy. Cell Rep. 2024;43(11):114868.","journal-title":"Cell Rep"},{"issue":"1","key":"4249_CR26","doi-asserted-by":"publisher","first-page":"22804","DOI":"10.1038\/s41598-023-50205-1","volume":"13","author":"J Chen","year":"2023","unstructured":"Chen J, Zhang L, Luo Y, Tan C, Hu H, Jiang Y, Xi N, Zeng Q, Peng H. Development of a ferroptosis-based molecular markers for predicting RFS in prostate cancer patients. Sci Rep. 2023;13(1):22804.","journal-title":"Sci Rep"},{"key":"4249_CR27","doi-asserted-by":"crossref","unstructured":"Liu Z, Zhao Q, Zuo ZX, Yuan SQ, Yu K, Zhang Q, Zhang X, Sheng H, Ju HQ, Cheng H et al. Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer. iScience 2020, 23(7):101302.","DOI":"10.1016\/j.isci.2020.101302"},{"issue":"D1","key":"4249_CR28","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han Y, Wang Y, Dong X, Sun D, Liu Z, Yue J, Wang H, Li T, Wang C. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 2023;51(D1):D1425\u201331.","journal-title":"Nucleic Acids Res"},{"key":"4249_CR29","doi-asserted-by":"publisher","first-page":"1372215","DOI":"10.3389\/fimmu.2024.1372215","volume":"15","author":"Z Huang","year":"2024","unstructured":"Huang Z, Chen X, Wang Y, Yuan J, Li J, Hang W, Meng H. SLC7A11 inhibits ferroptosis and downregulates PD-L1 levels in lung adenocarcinoma. Front Immunol. 2024;15:1372215.","journal-title":"Front Immunol"},{"issue":"5","key":"4249_CR30","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"key":"4249_CR31","doi-asserted-by":"publisher","first-page":"113524","DOI":"10.1016\/j.biopha.2022.113524","volume":"153","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Z, Sun W, Zhang J, Xu Q, Zhou X, Mao L. Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets. Biomed Pharmacother. 2022;153:113524.","journal-title":"Biomed Pharmacother"},{"issue":"1\u20132","key":"4249_CR32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331.","journal-title":"Cell"},{"issue":"1","key":"4249_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91\u20138.","journal-title":"Nat Chem Biol"},{"key":"4249_CR34","doi-asserted-by":"publisher","first-page":"628988","DOI":"10.3389\/fphar.2021.628988","volume":"12","author":"L FanZ, Cai","year":"2021","unstructured":"Fan Z, Cai L, Wang S, Wang J, Chen B. Baicalin Prevents Myocardial Ischemia\/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis. Front Pharmacol. 2021;12:628988. https:\/\/doi.org\/10.3389\/fphar.2021.628988","journal-title":"Front Pharmacol"},{"issue":"2","key":"4249_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gasc\u00f3n S, Hatzios SK, Kagan VE, et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017;171(2):273\u201385.","journal-title":"Cell"},{"issue":"1","key":"4249_CR36","doi-asserted-by":"publisher","first-page":"110762","DOI":"10.1016\/j.ygeno.2023.110762","volume":"116","author":"X Xie","year":"2024","unstructured":"Xie X, Zhao Y, Du F, Cai B, Fang Z, Liu Y, Sang Y, Ma C, Liu Z, Yu X, et al. Pan-cancer analysis of the tumorigenic role of Fanconi anemia complementation group D2 (FANCD2) in human tumors. Genomics. 2024;116(1):110762.","journal-title":"Genomics"},{"key":"4249_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.gene.2017.03.005","volume":"618","author":"J Wang","year":"2017","unstructured":"Wang J, Lee J, Liem D, Ping P. HSPA5 Gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum. Gene. 2017;618:14\u201323.","journal-title":"Gene"},{"issue":"5","key":"4249_CR38","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"J Dixon Scott","year":"2012","unstructured":"Dixon Scott J, Lemberg Kathryn M, Lamprecht Michael R, Skouta R, Zaitsev Eleina M, Gleason Caroline E, Patel Darpan N, Bauer Andras J, Cantley Alexandra M, Yang Wan S, et al. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"key":"4249_CR39","doi-asserted-by":"publisher","first-page":"938134","DOI":"10.3389\/fphar.2022.938134","volume":"13","author":"L Yang","year":"2022","unstructured":"Yang L, Zhang Y, Wang Y, Jiang P, Liu F, Feng N. Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis. Front Pharmacol. 2022;13:938134.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4249_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-022-01004-z","volume":"7","author":"B Gan","year":"2022","unstructured":"Gan B. ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity. Signal Transduct Target Therapy. 2022;7(1):128.","journal-title":"Signal Transduct Target Therapy"},{"key":"4249_CR41","doi-asserted-by":"publisher","first-page":"1098136","DOI":"10.3389\/fphar.2022.1098136","volume":"13","author":"L Hong","year":"2022","unstructured":"Hong L, Wang X, Cui W, Wang F, Shi W, Yu S, Luo Y, Zhong L, Zhao X. Construction of a ferroptosis scoring system and identification of LINC01572 as a novel ferroptosis suppressor in lung adenocarcinoma. Front Pharmacol. 2022;13:1098136.","journal-title":"Front Pharmacol"},{"issue":"5","key":"4249_CR42","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161(5):1215\u201328.","journal-title":"Cell"},{"issue":"6","key":"4249_CR43","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/genes13061094","volume":"13","author":"S Xu","year":"2022","unstructured":"Xu S, Zhou Y, Luo J, Chen S, Xie J, Liu H, Wang Y, Li Z. Integrated Analysis of a Ferroptosis-Related LncRNA Signature for Evaluating the Prognosis of Patients with Colorectal Cancer. Genes. 2022;13(6):1094. https:\/\/doi.org\/10.3390\/genes13061094","journal-title":"Genes"},{"issue":"5","key":"4249_CR44","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/cas.70015","volume":"116","author":"Y Yang","year":"2025","unstructured":"Yang Y, Ning Y, Chen Y, Tian T, Gao X, Kong Y, Lei K, Cui Z. Transferrin Receptor Promotes Endometrial Cancer Proliferation by Activating the Iron-Dependent PI3K\/AKT\/mTOR Signaling Pathway. Cancer Sci. 2025;116(5):1352\u201365.","journal-title":"Cancer Sci"},{"issue":"12","key":"4249_CR45","doi-asserted-by":"publisher","first-page":"10021","DOI":"10.3390\/ijms241210021","volume":"24","author":"B Jia","year":"2023","unstructured":"Jia B, Li J, Song Y, Luo C. ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries. Int J Mol Sci. 2023;24(12):10021. https:\/\/doi.org\/10.3390\/ijms241210021","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4249_CR46","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.chembiol.2022.08.002","volume":"29","author":"H Lee","year":"2022","unstructured":"Lee H, Gan B. Ferroptosis execution: Is it all about ACSL4? Cell Chem Biology. 2022;29(9):1363\u20135.","journal-title":"Cell Chem Biology"},{"issue":"18","key":"4249_CR47","doi-asserted-by":"publisher","first-page":"6913","DOI":"10.7150\/thno.100555","volume":"14","author":"SB Hansen","year":"2024","unstructured":"Hansen SB, Unal B, Kuzu OF, Saatcioglu F. Immunological facets of prostate cancer and the potential of immune checkpoint inhibition in disease management. Theranostics. 2024;14(18):6913\u201334.","journal-title":"Theranostics"},{"issue":"9","key":"4249_CR48","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41419-024-07098-3","volume":"15","author":"X Zhao","year":"2024","unstructured":"Zhao X, Zhao Z, Li B, Huan S, Li Z, Xie J, Liu G. ACSL4-mediated lipid rafts prevent membrane rupture and inhibit immunogenic cell death in melanoma. Cell Death Dis. 2024;15(9):695.","journal-title":"Cell Death Dis"},{"issue":"5","key":"4249_CR49","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/cells12050802","volume":"12","author":"N BedeschiM, Marino","year":"2023","unstructured":"Bedeschi M, Marino N, Cavassi E, Piccinini F, Tesei A. Cancer-associated fibroblast: role in prostate Cancer Progression to Metastatic Disease and Therapeutic Resistance. Cells. 2023;12(5):802. https:\/\/doi.org\/10.3390\/cells12050802","journal-title":"Cells"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04249-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04249-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04249-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:07:16Z","timestamp":1775740036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04249-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4249"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04249-8","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Second Affiliated Hospital of Xuzhou Medical University (Approval No. 2023-102322). All human participants involved in this study have provided written informed consent prior to their participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}